rs12449210
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001270974.2(HYDIN):c.-82A>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.339 in 1,535,590 control chromosomes in the GnomAD database, including 91,219 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 9703 hom., cov: 32)
Exomes 𝑓: 0.34 ( 81516 hom. )
Consequence
HYDIN
NM_001270974.2 5_prime_UTR
NM_001270974.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0750
Genes affected
HYDIN (HGNC:19368): (HYDIN axonemal central pair apparatus protein) This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 16-71230620-T-A is Benign according to our data. Variant chr16-71230620-T-A is described in ClinVar as [Benign]. Clinvar id is 402959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.556 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HYDIN | NM_001270974.2 | c.-82A>T | 5_prime_UTR_variant | 1/86 | ENST00000393567.7 | NP_001257903.1 | ||
HYDIN | NM_017558.5 | c.-82A>T | 5_prime_UTR_variant | 1/20 | NP_060028.2 | |||
HYDIN | NM_001198542.1 | c.58+10A>T | intron_variant | NP_001185471.1 | ||||
HYDIN | NM_001198543.1 | c.28+40A>T | intron_variant | NP_001185472.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HYDIN | ENST00000393567.7 | c.-82A>T | 5_prime_UTR_variant | 1/86 | 5 | NM_001270974.2 | ENSP00000377197 | P1 |
Frequencies
GnomAD3 genomes AF: 0.348 AC: 52884AN: 151774Hom.: 9673 Cov.: 32
GnomAD3 genomes
AF:
AC:
52884
AN:
151774
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.400 AC: 54708AN: 136730Hom.: 11809 AF XY: 0.391 AC XY: 29013AN XY: 74238
GnomAD3 exomes
AF:
AC:
54708
AN:
136730
Hom.:
AF XY:
AC XY:
29013
AN XY:
74238
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.337 AC: 466950AN: 1383696Hom.: 81516 Cov.: 38 AF XY: 0.338 AC XY: 230883AN XY: 682790
GnomAD4 exome
AF:
AC:
466950
AN:
1383696
Hom.:
Cov.:
38
AF XY:
AC XY:
230883
AN XY:
682790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.349 AC: 52968AN: 151894Hom.: 9703 Cov.: 32 AF XY: 0.349 AC XY: 25872AN XY: 74236
GnomAD4 genome
AF:
AC:
52968
AN:
151894
Hom.:
Cov.:
32
AF XY:
AC XY:
25872
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1658
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Primary ciliary dyskinesia 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at